Close Menu
    Facebook X (Twitter) Instagram
    Trending
    • New Zealand Thrash Australia 43-21 in Bledisloe Cup to Extend Winning Streak
    • Warhammer Age of Sigmar Reveals Three Khazalite Holds Armies of Renown Combining Duardin Forces
    • UK Households Could Face Higher Energy Bills Under Ofgem Plans to Protect Suppliers
    • Shark Nebula Image Wins Royal Observatory Greenwich Astronomy Photography Prize
    • Pre-Orders Open for Camp Snap 110 D Screen-Free Digital Camera
    • Researchers Used Claude to Exploit OpenAI Employee ChatGPT Accounts
    • Sigma Unveils 85mm f/1.2 DG Art as Its Fastest Portrait Lens Yet
    • South Park Creators Rename Show ‘South America’ in Apparent Trump Dig
    Mediarun Search
    • Home
    • Top News
    • World
    • Economy
    • Science
    • Technology
    • Sport
    • Entertainment
    • Contact Us
    Mediarun Search
    Home»World»AstraZeneca vaccine efficacy has ‘significant decline’
    World

    AstraZeneca vaccine efficacy has ‘significant decline’

    Oliver AshfordBy Oliver AshfordDecember 11, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    AstraZeneca vaccine efficacy has ‘significant decline’
    Share
    Facebook Twitter LinkedIn Pinterest Email

    AstraZeneca’s Covid-19 vaccine contains A ‘Significant decrease’ in efficacy when patient exposed to micron variableAccording to UK Health Safety Agency data released on Friday (12/10) by the BBC.

    The survey also notes a “significant” drop in the effectiveness of Pfizer’s vaccine against Covid-19. the Modern formulas or Janssen, but the agency believes it will also fall for the new alternative.

    in a Interview with the Guardian newspaperSusan Hopkins, the agency’s chief medical officer, says the data shows that anyone who received two doses more than three months ago is not without symptoms of Covid-19.

    According to the paper, individuals who took the AstraZeneca vaccine for more than 25 weeks had a 40% protection against cases with delta-variable symptoms and only 10% against Ômicron. However, the numbers are still uncertain, as few cases have been analyzed, and in the country, the immunizing agent has been given mainly to the elderly and patients in high-risk groups, who are traditionally more vulnerable to infection.

    Learn more about the micronized variant of the coronavirus:

    After the booster or third dose, protection is 75% against microns, slightly lower than the other variables. The analysis considered information from 581 patients with the variant and thousands with delta. The survey has not been published in a scientific journal or peer-reviewed yet.

    Although the data is preliminary, the British Health Agency reaffirms that vaccines are still available Protection from serious Covid-19 cases, hospitalizations and deaths. Information on symptom severity of patients with Micron should be published next week.

    Oliver Ashford

    Oliver Ashford is a contributor to Mediarunsearch.co.uk, covering a broad range of topics including news, politics, business, technology, sport, entertainment and lifestyle. He focuses on delivering clear, balanced reporting that helps readers stay informed about current affairs and developments that matter. With an emphasis on accuracy, relevance and accessibility, Oliver aims to present useful information and engaging stories in a straightforward manner, making complex topics easier for readers to understand and follow.

    See also  Putin and Schulz talk about peace talks in Ukraine | Ukraine and Russia
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Trump is boycotting the meeting with European leaders to contact Putin

    August 19, 2025

    Scientists depict the sea in the eye of Hurricane Irene; Examine

    August 18, 2025

    Pakistani monsoon rain leaves more than 350 people in 48 hours

    August 18, 2025
    Leave A Reply Cancel Reply

    Navigate
    • Home
    • Top News
    • World
    • Economy
    • Science
    • Technology
    • Sport
    • Entertainment
    • Contact Us
    Pages
    • About Us
    • Contact Us
    • DMCA
    • Editorial Policy
    • Privacy Policy
    © 2026 Media Run Search. All Rights Reserved. Designed by Media Run Search.

    Type above and press Enter to search. Press Esc to cancel.